Kim L B, Russkih G S, Putyatina A N, Tsypysheva O B
Research Institute of Experimental and Clinical Medicine, 2, Timakova srt., Novosibirsk, 630117, Russian Federation;
Research Institute of Biochemistry, 2, Timakova str., Novosibirsk, 630117, Russian Federation.
Adv Gerontol. 2018;31(2):223-230.
Here we present the study of enzymes involved in the regulation of extracellular matrix metabolism. It was the first study of this kind in the European part of the Arctic zone of the Russian Federation (AZRF). The contents of matrix metalloproteinases (MMP-1, -2, -3, -9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, -2, -4) were measured in blood plasma of 91 men in AZRF (67o N) and 14 men in Western Siberia. The contents of MMP-1, MMP-9, TIMP-1 and TIMP-4 in plasma of northerners were higher compared to those of the residents of Western Siberia (55o N). Age-related dynamics of MMP and TIMP contents had a mixed trend in northerners. The maximum contents of MMP-1 and MMP-9 and of MMP-3 were observed in 30-39 and 40-49 years old groups, respectively. The contents of these enzymes tended to decease with age. The maximum contents of TIMP-1 and TIMP-2 and of TIMP-4 were in 50-59 and 60-69 years old groups, respectively, while the minimum contents of these enzymes were in the group of young men up to 29 years old. Hyaluronidase activity was minimal in 30-39 years old group and increased with age up to maximum values at 50-59 years old. Age-related imbalance of MMP/TIMP system (MSE content reduction with age vs TIMP content increase in older age groups) can be considered one of the reasons of the identified age-related increase of interstitial fibrosis and premature aging of the northerners.
在此,我们展示了对参与细胞外基质代谢调节的酶的研究。这是在俄罗斯联邦北极区(AZRF)欧洲部分进行的此类首次研究。在AZRF(北纬67°)的91名男性和西西伯利亚的14名男性的血浆中测量了基质金属蛋白酶(MMP - 1、-2、-3、-9)和基质金属蛋白酶组织抑制剂(TIMP - 1、-2、-4)的含量。与西西伯利亚居民(北纬55°)相比,北方人血浆中MMP - 1、MMP - 9、TIMP - 1和TIMP - 4的含量更高。北方人MMP和TIMP含量的年龄相关动态呈现混合趋势。分别在30 - 39岁和40 - 49岁年龄组中观察到MMP - 1和MMP - 9以及MMP - 3的最高含量。这些酶的含量随年龄增长呈下降趋势。TIMP - 1和TIMP - 2以及TIMP - 4的最高含量分别在50 - 59岁和60 - 69岁年龄组中,而这些酶的最低含量在29岁及以下的年轻男性组中。透明质酸酶活性在30 - 39岁年龄组中最低,并随年龄增长而增加,在50 - 59岁时达到最大值。MMP/TIMP系统的年龄相关失衡(随着年龄增长MSE含量降低,而老年组中TIMP含量增加)可被视为北方人已确定的年龄相关间质纤维化增加和过早衰老的原因之一。